Heavy Metal Exposure in Predicting Peripheral Neuropathy in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy

Clinical trial NCT01982591 · COMPLETED

Trial details

NCT number: NCT01982591
Sponsor: Fox Chase Cancer Center
Status: COMPLETED
Study type: OBSERVATIONAL

Male Breast Cancer Neurotoxicity Peripheral Neuropathy Stage IA Breast Cancer Stage IB Breast Cancer Stage II Breast Cancer Stage IIIA Breast Cancer Stage IIIB Breast Cancer Stage IIIC Breast Cancer

Start date: 2011-01-03
Primary completion: 2015-03-24
Enrollment: 115

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.